Identifying something as a critical competitive industry, then place a bunch of hurdles in front of it's development, and sit confused when we get left behind - that's the EU special.
Pharma as a whole is still dwarfed by the trillion-dollar US tech giants that the EU has no equivalent of. One standout doesn't change the broader lag.